2m 2m 2m 2m 2m 2m 2m
ANI Pharmaceutic (ANIP)
NASDAQ
$81.15+$0.06 (+0.08%)
Price as of Jul 13, 2026 6:46 PM EDT- $1.8BMarket Cap
- 24.37%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ANI Pharmaceutic (ANIP)
$81.15+$0.06 (+0.08%)
ANIP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $81.08 | ||
Change | -$0.99 (-1.21%) | ||
Open | $81.84 | ||
High | $82.78 | ||
Low | $80.05 | ||
Previous Close | $82.07 | ||
Volume | 303,406 | ||
30-Day Average Volume | 341,491 | ||
1-Week Change | -4.67% | ||
1-Month Change | -0.73% | ||
1-Year Change | 24.37% | ||
3-Year Change | 60.40% | ||
5-Year Change | 141.45% | ||
Fundamentals | |||
Shares Outstanding | 22.7M | ||
Total Assets | $1.4B | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $237.5M | ||
Net Income | $29.5M | ||
Free Cash Flow | $52.3M | ||
EBIT | $44.0M | ||
EBITDA | $64.9M | ||
Net Working Capital | $507.6M | ||
EPS | $1.28 | ||
Enterprise Value/EBITDA | 28 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 3 | ||
P/E | 63 | ||
PEG | 7 | ||
Price/Free Cash Flow | 35 | ||
Price/Operating Cash Flow | 32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/04/2012 | ||
Earnings & Revenue